News
Arena and Eisai Complete End-of-Review Meeting with FDA
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin...
News
Lundbeck enters into drug discovery collaboration with Zenobia and Vernalis
H. Lundbeck A/S announced that it has signed agreements with Zenobia Therapeutics (Zenobia) and Vernalis plc (Vernalis) which will provide Lundbeck with access to know-how...
News
Merck Serono and San Raffaele Institute to Collaborate on Research
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced a strategic collaboration with the Institute of Experimental Neurology (INSpe) and the Department of Neurology...
News
Addex Awarded EuropaBio’s Most Innovative SME Award
Allosteric modulation company Addex Pharmaceuticals announced that the company has been awarded EuropaBio’s Most Innovative SME Award. This is the first time that the award...
News
Fluxion Biosciences Announces Product Launch of BioFlux 1000Z
Fuxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell Biology...
News
GSK signs agreement to acquire Nanjing MeiRui Pharmaceuticals
GlaxoSmithKline plc announced that it has entered into an agreement to acquire Nanjing MeiRui Pharma Co., Ltd (MeiRui) for a cash consideration of approximately $70...
News
Elan Drug Technologies Announces Completion of Enrolment in Phase 3
Elan Drug Technologies, a business unit of Elan Corporation, plc announced that Zogenix Inc, its licensee, has completed enrolment in its open-label Phase 3 study...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.